Gregor Hutter
Founder & Chief Medical Officer GlioCART
Gregor Hutter is Full Professor of Neurosurgery at University Hospital Basel, where he works as a neurosurgeon and Research Group Leader in the Brain Tumor Immunotherapy Lab. His research focuses on brain tumor immunotherapy, particularly glioblastoma and the interactions between tumor-associated macrophages and cancer cells. He is also Founder and Chief Medical Officer of glioCART, focused on developing CAR T-cell therapies for glioblastoma. Gregor completed his neurosurgery residency at the University of Basel and holds a PhD in Molecular Biology, with a focus on Immunology, from the University of Zurich.
Seminars
Tuesday 9th February 2027
Keynote Presentation: Building Novel Dual-Action CAR-Ts to Effectively Balance Safety & Efficacy
9:30 am
- Highlighting dual-action CAR targeting the microenvironment and tumour cells
- Targeting macrophages to overcome immunosuppression in solid brain tumours
- Sharing emerging clinical data to evaluate the safety, efficacy, and reliability of CAR-T approaches
